According to World Health Organization (WHO), Coronaviruses are a large family of viruses
which can infect birds and mammals, including humans. At the end of 2019 in Wuhan …

Abstract Coronavirus disease 2019 (COVID-19) is a disease spreading rapidly in Sudan, the
rest of the African continent and the world with no known definitive treatment or vaccines …

SUMMARY about 4 days and showed less death rate [1/21 versus 8/28 in control group]. In
addition, all the patients who were given convalescent plasma showed high levels of SARS …

This paper aims to make suggestions for a small step forward in both preventative and
therapeutic measures against the Coronavirus disease 2019 (COVID 19) pandemic. This …

• There is some evidence for favourable outcomes in patients who have received COVID-19
convalescent plasma, but it is not definitive. WHO recognizes COVID-19 convalescent …

Convalescent plasma therapy has been used to achieve passive immunization against
diverse infectious agents by administering pathogen-specific antibodies. Coronavirus …

Abstract Aim Convalescent Plasma (CP) therapy is of interest as no vaccine or specific
treatment is available for emerging viruses such as severe acute respiratory syndrome …

Background and Objectives: On 24 March 2020, the United States Food and Drug
Administration (FDA) announced the approval of convalescent plasma therapy for critically ill …

Immunosuppressed patients such as solid organ transplant and hematologic malignancy
patients appear to be at increased risk for morbidity and mortality due to coronavirus disease …

The pandemic COVID-19 has spread widely throughout the globe and has been responsible
for millions of deaths worldwide. Recently, it has been identified that there is no specific and …